Literature DB >> 10715059

Hepatocellular adenoma: multiphasic CT and histopathologic findings in 25 patients.

T Ichikawa1, M P Federle, L Grazioli, M Nalesnik.   

Abstract

PURPOSE: To evaluate multiphasic computed tomographic (CT) findings of hepatic adenomas and to correlate these findings with those of histopathologic analysis.
MATERIALS AND METHODS: Multiphasic helical CT was performed in 25 patients with 44 hepatic adenomas. Nonenhanced scans were obtained in all cases, along with hepatic arterial-dominant phase (HAP) and portal venous-dominant phase (PVP) images at 25-28 and 60-70 seconds after intravenous contrast material injection at 3-5 mL/sec. Twelve patients with 24 adenomas also underwent delayed-phase (5-10-minute) CT. Two independent readers retrospectively reviewed each case for the number of detectable lesions in each CT phase, morphologic features of tumors, and degrees of enhancement.
RESULTS: Thirteen patients had solitary adenomas; 12 patients had two or three adenomas. Both observers agreed on the numbers of lesions detected in all cases and in all phases of enhancement. The detection rate for all 44 adenomas per type of examination was as follows: nonenhanced, 86% (38 of 44); HAP, 100% (44 of 44); PVP, 82% (36 of 44), and delayed, 88% (21 of 24). Tumor margins were well defined in 38 adenomas (86%), and the surface was smooth in 42 adenomas (95%). The right hepatic lobe was the only site of adenoma or was a site along with the left lobe in 29 cases (66%). Tumor fat and calcifications were uncommon (three cases [7%] and two cases [5%], respectively). Other than areas of fat, hemorrhage, or necrosis, the adenomas enhanced nearly homogeneously, especially on PVP and delayed-phase scans. Five patients had coexistent hepatic masses, which were focal nodular hyperplasia (n = 3) or hepatocellular carcinoma (n = 2).
CONCLUSION: Hepatic adenomas often have characteristic features at multiphasic CT that may allow their distinction from other hepatic masses.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10715059     DOI: 10.1148/radiology.214.3.r00mr28861

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  38 in total

1.  Liver-specific contrast agent-enhanced magnetic resonance and ¹⁸F-fluorodeoxyglucose positron emission tomography findings of hepatocellular adenoma: report of a case.

Authors:  Tatsuaki Sumiyoshi; Michihisa Moriguchi; Hideyuki Kanemoto; Kouiku Asakura; Keiko Sasaki; Teiichi Sugiura; Takashi Mizuno; Katsuhiko Uesaka
Journal:  Surg Today       Date:  2011-12-10       Impact factor: 2.549

Review 2.  Focal nodular hyperplasia and hepatic adenoma: current diagnosis and management.

Authors:  Agustin Cristiano; Agustin Dietrich; Juan Carlos Spina; Victoria Ardiles; Eduardo de Santibañes
Journal:  Updates Surg       Date:  2013-06-27

Review 3.  Benign liver lesions: grey-scale and contrast-enhanced ultrasound appearances.

Authors:  A E Obaro; S M Ryan
Journal:  Ultrasound       Date:  2015-03-12

Review 4.  Evaluation of nonmalignant liver masses.

Authors:  Wojciech Blonski; K Rajender Reddy
Journal:  Curr Gastroenterol Rep       Date:  2006-02

5.  Malignant transformation of hepatic adenoma with recurrence after resection.

Authors:  Kenneth A Larson; Sharon M Weber; Yuman Fong; Leslie H Blumgart
Journal:  HPB (Oxford)       Date:  2002       Impact factor: 3.647

6.  Malignant transformation of hepatocellular adenoma: how frequently does it happen?

Authors:  M Kudo
Journal:  Liver Cancer       Date:  2015-03       Impact factor: 11.740

Review 7.  Differentiation of hepatocellular carcinoma from its various mimickers in liver magnetic resonance imaging: What are the tips when using hepatocyte-specific agents?

Authors:  Yang Shin Park; Chang Hee Lee; Jeong Woo Kim; Sora Shin; Cheol Min Park
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

8.  Hepatocyte nuclear factor 1α-inactivated hepatocellular adenomas exhibit high (18)F-fludeoxyglucose uptake associated with glucose-6-phosphate transporter inactivation.

Authors:  Kumi Ozaki; Kenichi Harada; Noboru Terayama; Osamu Matsui; Satoshi Saitoh; Yoshito Tomimaru; Takeshi Fujii; Toshifumi Gabata
Journal:  Br J Radiol       Date:  2016-05-20       Impact factor: 3.039

Review 9.  Exophytic benign and malignant hepatic tumors: CT imaging features.

Authors:  Hyoung Jung Kim; Dong Ho Lee; Joo Won Lim; Young Tae Ko; Kyoung Won Kim
Journal:  Korean J Radiol       Date:  2008 Jan-Feb       Impact factor: 3.500

Review 10.  Distinguishing benign from malignant liver tumours.

Authors:  Jay P Heiken
Journal:  Cancer Imaging       Date:  2007-10-01       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.